Minister of Finance Charilaos Stavrakis and Vice President of the European Investment Bank (EIB) Ploutarchos Sakellaris signed an agreement of guarantees on Thursday, providing for a loan of 30 million EUR from
Weakness in miners and financials dragged Britain's top share index 0.9 percent lower by midday on Friday, as weak data this week increased investors' concerns, denting risky assets ahead of U.S. non-farm
U.S. auto sales tumbled by 23 percent in September as showrooms emptied after the government-funded boom from the "cash for clunkers" program, with General Motors Co and Chrysler hardest-hit. Sales for General
British house prices rose for a fifth month running in September to leave them flat year-on-year, the Nationwide Building Society said on Friday, in a further sign that the housing market is
EDF plans to sell EDF Energy, Britain's largest power distribution business, for more than 4 billion euros ($5.8 billion) to help cut debt, the French group said on Friday. The world's largest
Federal Reserve officials said on Thursday that while the recession-battered economy is on the mend, it will be weak for a while and the Fed is likely to keep its extensive support
Futures for the Dow Jones industrial average, the S&P 500 and the Nasdaq 100 fall 0.3-0.4 percent, pointing to a weaker start on Wall Street on Friday. The U.S. Labor Department releases
IBM is introducing an inexpensive Web-based corporate email service that will compete with Google Inc's Google Apps, which has recently suffered several high-profile outages. International Business Machines Corp will likely try to
The Council of Europe Commissioner for Human Rights, Thomas Hammarberg, has asked Turkey to establish an effective national human rights institution and to create and implement a comprehensive anti-discrimination legislation. Commissioner Hammarberg
From October 5, Cyprus will gradually begin receiving the vaccine for influenza H1N1, Minister of Health Christos Patsalides announced, adding that vaccinations will begin after October 15, when the European Pharmaceutical Organisation
